{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:05:05Z","timestamp":1793754305250,"version":"4.6.1"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.msard.2020.102051","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T11:40:21Z","timestamp":1584186021000},"page":"102051","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9720-3204","authenticated-orcid":false,"given":"Katarzyna","family":"Kapica-Topczewska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Tarasiuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Chor\u0105\u017cy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Czarnowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7955-3454","authenticated-orcid":false,"given":"Waldemar","family":"Brola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Szczepa\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kochanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Ku\u0142akowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102051_bib0001","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1212\/WNL.0000000000001187","article-title":"Comorbidity increases the risk of hospitalizations in multiple sclerosis","volume":"84","author":"Marrie","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0002","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1212\/WNL.0000000000004716","article-title":"Comorbidity increases the risk of relapse in multiple sclerosis: a prospective study","volume":"89","author":"Kowalec","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0003","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.msard.2017.07.010","article-title":"Tackling comorbidity in multiple sclerosis","volume":"17","author":"Kobelt","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102051_bib0004","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/WNL.0000000000004508","article-title":"Comorbidity in multiple sclerosis is associated with diagnostic delays and increased mortality","volume":"89","author":"Thormann","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0005","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrneurol.2017.33","article-title":"Comorbidity in multiple sclerosis: implications for patient care","volume":"13","author":"Marrie","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.msard.2020.102051_bib0006","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1212\/WNL.0000000000002471","article-title":"The challenge of comorbidity in clinical trials for multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0007","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102051_bib0008","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1212\/WNL.0000000000004686","article-title":"iMUST group assessing association of comorbidities with treatment choice and persistence in MS: a real-life multicenter study","volume":"89","author":"Laroni","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0009","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1212\/WNL.0000000000002543","article-title":"Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis","volume":"86","author":"Zhang","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.msard.2018.02.016","article-title":"Prevalence of multiple sclerosis inPoland","volume":"21","author":"Kapica-Topczewska","year":"2018","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102051_bib0011","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.msard.2015.07.014","article-title":"Comorbidity is associated with pain-related activity limitations in multiple sclerosis","volume":"4","author":"Fiest","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2020.102051_bib0012","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","article-title":"Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0013","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1352458515588973","article-title":"Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis","volume":"22","author":"Hoang","year":"2016","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2020.102051_bib0014","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.comppsych.2015.08.001","article-title":"Psychiatric disorders in patients with multiple sclerosis","volume":"63","author":"de Cerqueira","year":"2015","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.msard.2020.102051_bib0015","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1212\/WNL.0000000000002474","article-title":"Recommendations for observational studies of comorbidity in multiple sclerosis","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1212\/CPJ.0000000000000230","article-title":"Differing trends in the incidence of vascular comorbidity in MS and the general population","volume":"6","author":"Marrie","year":"2016","journal-title":"Neurol. Clin. Pract."},{"key":"10.1016\/j.msard.2020.102051_bib0017","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000320245","article-title":"Risk of arterial cardiovascular diseases in patients with multiple sclerosis: a population-based cohort study","volume":"35","author":"Christiansen","year":"2010","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2020.102051_bib0018","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1007\/s00415-016-8295-9","article-title":"Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark","volume":"263","author":"Thormann","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2020.102051_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jns.2014.10.020","article-title":"Vascular comorbidities in the onset and progression of multiple sclerosis","volume":"347","author":"Tettey","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102051_bib0020","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1212\/WNL.0b013e3181d6b125","article-title":"Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2020.102051_bib0021","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0028-3843(14)60134-1","article-title":"Selected aspects of the epidemiology of multiple sclerosis in Poland\u2013a multicentre pilot study","volume":"44","author":"Ku\u0142akowska","year":"2010","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.msard.2020.102051_bib0022","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/00207454.2014.937002","article-title":"Demographic characteristics of MS patients in Poland's upper Silesia region","volume":"125","author":"Pierzchala","year":"2015","journal-title":"Int. J. Neurosci."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820301279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820301279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:50:34Z","timestamp":1761900634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820301279"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":22,"alternative-id":["S2211034820301279"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102051","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The epidemiology of comorbidities among multiple sclerosis patients in northeastern Poland","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102051"}}